Depression Clinical Trial
Official title:
To Explore the Influence of Different Anesthesia Induction Schemes on the Quality and Clinical Effect of Electroconvulsive Convulsions in Patients With Depression Based on EEG Monitoring
Depression is a common clinical mental disease with high incidence rate, high recurrence rate, high suicide rate and high disability rate. As a first-line treatment for depression with refractory, high suicide risk and obvious psychotic symptoms, electric shock has a definite effect on depression, but may lead to cognitive impairment. The induction of extensive epileptiform discharges in the cerebral cortex by electric shock therapy is the key to ensure the treatment effect. The level of epileptiform discharges in the brain is mainly reflected in the quality of convulsions. The quality of electroconvulsive convulsions is affected by factors such as age, stimulation power, anesthetic drugs and depth of anesthesia. Most anesthetics have anticonvulsive properties, such as barbiturate or propofol, which may have a negative impact on the quality of convulsions, thus affecting the therapeutic effect. If the parameters of electric shock, such as stimulation dose, are modified, although the quality and treatment effect of convulsions can be improved, it may also lead to higher cognitive side effects. The depth of anesthesia also affects the quality and efficacy of electric shock convulsions, and the quality of convulsions is higher when stimulated at a shallow level of anesthesia. However, if the use of narcotic drugs is reduced to improve the quality of convulsions, the risk of restlessness and delirium after electric shock may be higher and the comfort of patients may be lower. Therefore, this study compared the effects of different anesthesia induction schemes on the quality and clinical efficacy of electroconvulsive seizures in patients with depression based on EEG monitoring, and explored the optimal depth of anesthesia.
Status | Recruiting |
Enrollment | 24 |
Est. completion date | August 31, 2024 |
Est. primary completion date | March 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - In-patients who meet the diagnostic criteria of moderate and severe depression in the 11th edition of the International Classification of Diseases (ICD-11) - Age 18-60 years old, gender unlimited - Primary school or above education level - Indications for MECT treatment - Normal hearing and vision (including color discrimination) - The patient voluntarily participated in the study and signed the informed consent form, and the guardian also signed the informed consent form. Exclusion Criteria: - History of physical disease, brain organic disease and abuse of alcohol and psychoactive substances - Patients with bipolar disorder - Primary insomnia - Combined with other mental diseases - Combined with obesity, diabetes and other metabolic diseases - Combined with hypertension, cardiovascular disease or cerebrovascular disease - Combined with Alzheimer's disease - Pregnant and lactating women. |
Country | Name | City | State |
---|---|---|---|
China | The First Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing |
Lead Sponsor | Collaborator |
---|---|
Min Su |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | EEG seizure duration | Duration of EEG convulsions, in seconds,the most important index of the quality of EEG during the treatment of electric shock | up to 30 minutes after each electroconvulsive treatment | |
Secondary | average Seizure Energy Index(SEI) | Indicator of quality of convulsive, in uV2 | up to 30 minutes after each electroconvulsive treatment | |
Secondary | electric shock stimulation energy | Indicator of electric shock stimulation energy, in mC | up to 30 minutes after each electroconvulsive treatment | |
Secondary | post-seizure inhibition index | Indicator of quality of convulsive, in % | up to 30 minutes after each electroconvulsive treatment | |
Secondary | Bispectral EEG monitoring index | Depth of sedation and injury stress index,Value range 0-100 | up to 30 minutes after each electroconvulsive treatment | |
Secondary | Maximun heart rate | Maximum heart rate during electrical stimulation,in times/minute | up to 30 minutes after each electroconvulsive treatment | |
Secondary | Hamilton score | Depression score,A total score of 81 points, = 8 points without depression, 8-20 points with possible depression, 20-35 points with mild to moderate depression, = 35 points with severe depression | through study completion, an average of 1 year | |
Secondary | Montreal cognitive score | cognitive function assessment,A total score of 30 points,<26 points determines the presence of cognitive impairment | through study completion, an average of 1 year | |
Secondary | Recovery period restlessness | Complications during anesthesia recovery,Using Richmond restless sedation scale | up to 4 hours after each electroconvulsive treatment | |
Secondary | Recovery period delirium | Complications during anesthesia recovery,Using CAM-ICU scale | up to 4 hours after each electroconvulsive treatment | |
Secondary | Recovery period nausea and vomiting | Complications during anesthesia recovery,Using index of nausea and vomiting and retching(R-INVR) | up to 4 hours after each electroconvulsive treatment | |
Secondary | Recovery period muscle soreness, headache, dizziness | Complications during anesthesia recovery,Using 0 for none, 1 for yes | up to 4 hours after each electroconvulsive treatment | |
Secondary | interval between anesthesia induction and the start of electrical stimulation | Time to wait for electrical stimulation after administration,in seconds | up to 4 hours after each electroconvulsive treatment | |
Secondary | intraoperative awareness | During general anesthesia, consciousness recovery occurs, and the patient has a certain degree of perception and memory of the surrounding environment or sound. After general anesthesia, the patient can recall what happened during the surgery and be informed of any pain or other conditions. Events occurring before induction to sleep and after awakening from anesthesia were not included. | up to 4 hours after each electroconvulsive treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A |